戻る Agenda
Session 1: The Role Of QPPV: Future Challenges And Expectations
Session Chair(s)
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
Elspeth McIntosh, MBA, RN
Director
Castle Pharmacovigilance Ltd, United Kingdom
The Role Of QPPV : Future Challenges and Expectations
Speaker(s)
Big Pharma/Governance QPPV
Jan Cleerbout, MD
Johnson & Johnson, Belgium
Senior Director, deputy EU QPPV
Midsize Pharma/ Operational QPPV
Gemma Jimenez Sese
AstraZeneca, Spain
Senior Director, Deputy EU QPPV
Outsourced/Support QPPV: CRO QPPV
Elspeth McIntosh, MBA, RN
Castle Pharmacovigilance Ltd, United Kingdom
Director